Amarin Corporation plc

US$11.61As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AMRNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (15.45%)
Div yield —
ROE (4.24%)
Drug Manufacturers (General)
Beta (5Y) 0.79
PE TTM —
TSR TTM (28.73%)
Mkt cap US$244.7M
ROIC (18.58%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$12
6.77%
(62.75%)
Hold 8|2|9|8|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.17
0.19
0.18
0.18
16.37%
35.99%
32.49%
16.57%
Revenue$M
15.67
15.23
15.89
16.33
12.06%
3.99%
7.77%
8.89%
Peers (US$244.7M)
Cap (US$)
PE
237.7M
155.7x
Capital
TTM
5Y
10Y
Leveragex
1.173
(0.030)
(0.022)
EBIT/Intx
1.245
0.058
0.062
Own earn%
(20.08)
(28.46)
(34.85)
Sh yield%
20.28
47.50
46.03
Owners
Insiders/Inst%
5.61
67.09
Short interest%
1.19
SBC / revenue%
5.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
13–17
$1 testx
—
Incr. ROIC%
55